Decitabine treatment demethylates vast majority of high-confidence differentially methylated regions in HCT-116 colorectal cancer cells
Open Access
- 4 August 2020
- journal article
- research article
- Published by F1000 Research Ltd in F1000Research
- Vol. 9, 886
Abstract
Background:Gene silencing by CpG island hypermethylation often plays a role in colorectal cancer (CRC) progression. Certain regions of the genome, called high confidence differentially-methylated regions (DMRs), are consistently hypermethylated across numerous patient samples. Methods:In this study, we used bioinformatics and bisulfite PCR sequencing of HCT-116 cells to investigate methylation levels at DMRs in the promoters of six genes:DKK3, EN1, MiR34b, SDC2, SPG20, andTLX1. We then investigated whether the anti-cancer drug decitabine, had a demethylating effect at these promoter regions. Results:We found that hypermethylation correlated with lack of transcriptional enhancer binding in these six regions. Importantly, we observed that for all DMRs, decitabine significantly reduced CpG methylation. Decitabine also reduced clonogenic survival, suggesting that there is a correlation between lower CpG island methylation levels and reduced cancerous properties. Conclusions:Our study provided single-nucleotide resolution and revealed hypermethylated CpG sites not shown by previous genome-wide methylation studies. In the future, we plan to perform experiments that demonstrate a causal link between promoter hypermethylation and carcinogenesis and that more accurately model treatments in CRC patients.Keywords
Funding Information
- Lake Forest College
- Sherman Fairchild Foundation
This publication has 37 references indexed in Scilit:
- Expectations of outcomes in patients with colorectal cancerBJS Open, 2018
- Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancerBMC Cancer, 2017
- Colorectal cancerNature Reviews Disease Primers, 2015
- Genetics, diagnosis and management of colorectal cancer (Review)Oncology Reports, 2015
- Mining cancer methylomes: prospects and challengesTrends in Genetics, 2014
- Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissuesEpigenetics, 2012
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shoresNature Genetics, 2009
- Characterization of HCT116 Human Colon Cancer Cells in an Orthotopic ModelJournal of Surgical Research, 2008
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cellsNature, 2002